Abstract
A novel class of potent FXIII-A inhibitors containing a (±) cis-bisamido epoxide pharmacophore is described. The compounds display highly potent inhibition of FXIII-A (IC50 Combining double low line 5-500 nM) in an in vitro assay. In contrast to other types of previously described covalent transglutaminase inhibitors, the bis-Amido epoxides exhibited no measurable reactivity with glutathione, therefore possibly rendering this class of compounds suitable for future in vivo investigations. Additionally, the compounds show selective inhibition for FXIII-A against the cysteine protease, cathepsin S although they proved to have similar potency with a closely related transglutaminase, TGII, to that observed for FXIII-A.
| Original language | English |
|---|---|
| Pages (from-to) | 49-53 |
| Number of pages | 5 |
| Journal | European Journal of Medicinal Chemistry |
| Volume | 98 |
| DOIs | |
| Publication status | Published - 26 May 2015 |
| Externally published | Yes |
Keywords
- Bis-Amido epoxides molecular modelling
- FXIII-A
- Thrombosis
Fingerprint
Dive into the research topics of '(±) cis-bisamido epoxides: A novel series of potent FXIII-A inhibitors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver